Rasmussen TB, Hansen J, Nissen PH, Palmfeldt J, Dalager S, Jensen UB, Kim WY, Heickendorff L, Mølgaard H, Jensen HK, et al. 2013.
Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms.
Clinical Genetics. 84(1):20-30.
https://doi.org/10.1111/cge.12056
Seitz AK, Christensen LL, Christensen E, Faarkrog K, Ostenfeld MS, Hedegaard J, Nordentoft I, Nielsen MM, Palmfeldt J, Thomson M, et al. 2017.
Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.
Scientific Reports. 7(1):Article 395.
https://doi.org/10.1038/s41598-017-00327-0
Merinero B, Perez-Cerda C, Ruiz Sala P, Ferrer I, Garcia MJ, Martinez Pardo M, Belanger-Quintana A, de la Mota JL, Martin-Hernandez E, Vianey-Saban C, et al. 2007.
Persistent increase of plasma butyryl/isobutyrylcarnitine concentrations as marker of SCAD defect and ethylmalonic encephalopathy. J. Inherit. Metab. Dis. 29(5):685.
Furuya H, Sasaki Y, Chen R, Peres R, Hokutan K, Murakami K, Kim N, Chan OTM, Pagano I
, Dyrskjøt L, et al. 2022.
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.
Scientific Reports. 12(1):Article 12186.
https://doi.org/10.1038/s41598-022-16518-3
Straadt IK, Young JF, Petersen BO, Duus JØ
, Gregersen N, Bross P, Oksbjerg N, Theil PK, Bertram HC. 2010.
Oxidative stress-induced metabolic changes in mouse C2C12 myotubes studied with high-resolution 13C, 1H, and 31P NMR spectroscopy.
Journal of Agricultural and Food Chemistry. 58(3):1918-26.
https://doi.org/10.1021/jf903505a